Infectious Disease Diagnostic Market

The global infectious disease diagnostic market size was valued at USD 17.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2021 to 2028. The market is driven by factors such as the increasing prevalence of infectious diseases, the growing adoption of point-of-care testing, and the increasing use of advanced technologies in diagnostic testing.

Key players in the infectious disease diagnostic market include Abbott Laboratories, BD, Bio-Rad Laboratories, F. Hoffmann-La Roche, Hologic, Inc., Danaher Corporation, Siemens AG, Thermo Fisher Scientific, Inc., and bioMérieux SA. These companies are investing in research and development to develop new and innovative diagnostic tests and are also engaging in strategic collaborations and partnerships to strengthen their market position.

The infectious disease diagnostic market size is expected to reach $22.87 billion by 2026, growing at a CAGR of 6.5% during the forecast period from 2020 to 2026. Factors driving growth in this market include increasing incidence of infectious diseases, rising government funding for the development of diagnostic tests, and increasing adoption of point-of-care testing.

Key players in the infectious disease diagnostic market include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Hologic, Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., and Qiagen N.V. among others.